Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
JPMorgan Chase & Co reported a 5.10% stake in Regeneron Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 22, 2025
JPMorgan Chase & Co reported a 5.10% stake in Regeneron Pharmaceuticals, Inc., 5,546,434 shares, as a passive investor on Mar 31, 2025. Filed Apr 22, 2025 (Schedule 13G/A).
- Stake
- 5.10%
- Shares
- 5,546,434
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 5.10% | 5,546,434 |
Source
Related
- Regeneron Pharmaceuticals, Inc.
- JPMorgan Chase & Co
- Regeneron Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · JPMorgan Chase & Co · Jun 5, 2025
- Form 4 · Murphy Andrew J · Oct 15, 2026
- Form 4 · McCourt Marion · Sep 3, 2026
- Form 4 · Guarini Kathryn · Sep 3, 2026
- Form 4 · Larosa Joseph J · Aug 21, 2026
- Form 4 · Fenimore Christopher R. · Aug 20, 2026